Revolution Medicines director receives stock and option grants
Revolution Medicines director Elizabeth M. Anderson reported compensation-related equity grants and updated holdings.
Rhea-AI Filing Summary
Revolution Medicines director Elizabeth M. Anderson reported compensation-related equity grants and updated holdings. She received 1,191 shares of common stock as a grant of restricted stock units and a stock option for 3,127 shares at an exercise price of $162.99 per share.
The option covers 3,127 shares of common stock and expires on June 18, 2036. These option shares vest in full on the earlier of the first anniversary of June 18, 2026 or immediately before the next Annual Meeting after the grant date, assuming she continues as a service provider.
After these awards, Anderson directly holds 9,406 shares of common stock, which include the 1,191 restricted stock units. Separately, 26,990 shares of common stock are held indirectly through the David W. Anderson 1996 Irrevocable Trust.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 4,318 shares
Grant/Award
3 txns
Insider
ANDERSON ELIZABETH M
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 3,127 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 1,191 | $0.00 | $0.00 |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 3,127 contracts (Direct);
Common Stock — 9,406 shares (Direct);
Common Stock — 26,990 shares (Indirect, See footnote)
Footnotes (3)
- F1. Includes 1,191 restricted stock units.
- F2. Held by David W. Anderson 1996 Irrevocable Trust.
- F3. Shares subject to the Option shall vest in full on the earlier of (i) the first anniversary of June 18, 2026 or (ii) immediately prior to the Annual Meeting following the date of grant subject to the Reporting Person remaining a Service Provider (as defined in the 2020 Plan) through the vesting date.
Key Figures
RSU grant: 1,191 shares
Option grant size: 3,127 shares
Option exercise price: $162.99 per share
+3 more
6 metrics
RSU grant
1,191 shares
Restricted stock units granted to director
Option grant size
3,127 shares
Stock Option (Right to Buy) underlying common shares
Option exercise price
$162.99 per share
Conversion or exercise price for stock option
Option expiration
June 18, 2036
Expiration date of stock option grant
Direct common shares after grant
9,406 shares
Total common stock directly held after transactions
Indirect trust-held shares
26,990 shares
Common stock held by David W. Anderson 1996 Irrevocable Trust
Key Terms
restricted stock units, Stock Option (Right to Buy, indirect ownership, Annual Meeting, +1 more
5 terms
restricted stock units financial
"Includes 1,191 restricted stock units."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Stock Option (Right to Buy financial
"security_title: "Stock Option (Right to Buy)""
indirect ownership financial
"direct_or_indirect: "I", ownership_type: "indirect""
Annual Meeting financial
"immediately prior to the Annual Meeting following the date of grant"
A company's annual meeting is a yearly gathering where owners (shareholders) and the board review performance, ask questions, and vote on key matters like electing directors, approving auditor choices, and sometimes setting pay or dividend policies. For investors it matters because decisions made and votes cast can change who runs the company, influence strategy and payouts, and affect the value or direction of their investment—similar to a homeowners’ meeting where rules and leaders that shape your property’s value are decided.
service provider financial
"subject to the Reporting Person remaining a Service Provider"
FAQ
What equity awards did Elizabeth M. Anderson receive in this RVMD Form 4 filing?
Elizabeth M. Anderson received a grant of 1,191 restricted stock units and a stock option for 3,127 shares of Revolution Medicines common stock at an exercise price of $162.99 per share as part of her director compensation.
What are the vesting terms of Elizabeth M. Anderson’s new RVMD stock option?
The new stock option for 3,127 shares of Revolution Medicines common stock vests in full on the earlier of the first anniversary of June 18, 2026 or immediately before the next Annual Meeting, assuming she continues as a service provider.
What is the exercise price and expiration date of Anderson’s RVMD stock option grant?
The stock option granted to Elizabeth M. Anderson has an exercise price of $162.99 per share and covers 3,127 shares. The option expires on June 18, 2036, providing a long-dated right to purchase Revolution Medicines common stock.
AI-generated analysis. How Rhea-AI works. Not financial advice.
